The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine
Open accessAbstract
Background— The development of selective atrial antiarrhythmic agents is a current strategy for suppression of atrial fibrillation (AF). Methods and Results— Whole-cell patch clamp techniques were used to evaluate inactivation of peak sodium channel current ( I Na ) in myocytes isolated from canine atria and ventricles. The electrophysiological effects of therapeutic concentrations of ranolazine (1 to 10 μmol/L) and lidocaine (2.1 to 21 μmol/L) were evaluated in canine isolated coronary-perfused atrial and ventricular preparations. Half-inactivation voltage of I Na was ≈15 mV more negative in atrial versus ventricular cells under control conditions; this difference increased after exposure to ranolazine. Ranolazine produced a marked use-dependent depression of sodium channel parameters, including the maximum rate of rise of the action potential upstroke, conduction velocity, and diastolic threshold of excitation, and induced postrepolarization refractoriness in atria but not in ventricles. Lidocaine also preferentially suppressed these parameters in atria versus ventricles, but to a much lesser extent than ranolazine. Ranolazine produced a prolongation of action potential duration (APD 90 ) in atria, no effect on APD 90 in ventricular myocardium, and an abbreviation of APD 90 in Purkinje fibers. Lidocaine abbreviated both atrial and ventricular APD 90 . Ranolazine was more effective than lidocaine in terminating persistent AF and in preventing the induction of AF. Conclusions— Our study demonstrates important differences in the inactivation characteristics of atrial versus ventricular sodium channels and a striking atrial selectivity for the action of ranolazine to produce use-dependent block of sodium channels, leading to suppression of AF. Our results point to atrium-selective sodium channel block as a novel strategy for the management of AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,300
Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties
Antzelevitch, C., Belardinelli, L., Zygmunt, A. C., Burashnikov, A., Di Diego, J. M., Fish, J. M., Cordeiro, J. M., & Thomas, G. (2004) · Circulation · doi:10.1161/01.cir.0000139333.83620.5d · Cited by 675
Self-citationThe M Cell: Its Contribution to the ECG and to Normal and Abnormal Electrical Function of the Heart
ANTZELEVITCH, C., SHIMIZU, W., YAN, G., SICOURI, S., WEISSENBURGER, J., NESTERENKO, V. V., BURASHNIKOV, A., DI DIEGO, J., SAFFITZ, J., & THOMAS, G. P. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00287.x · Cited by 611
Self-citationBurashnikov, A., & Antzelevitch, C. (2003) · Circulation · doi:10.1161/01.cir.0000065578.00869.7c · Cited by 310
Self-citationRanolazine for the Treatment of Chronic Angina and Potential Use in Other Cardiovascular Conditions
Chaitman, B. R. (2006) · Circulation · doi:10.1161/circulationaha.105.597500 · Cited by 294
UNDROVINAS, A. I., BELARDINELLI, L., UNDROVINAS, N. A., & SABBAH, H. N. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00401.x · Cited by 266
Self-citationAntiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT Syndrome
Wu, L., Shryock, J. C., Song, Y., Li, Y., Antzelevitch, C., & Belardinelli, L. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066100 · Cited by 193
Self-citationBlaauw, Y., Gögelein, H., Tieleman, R. G., van Hunnik, A., Schotten, U., & Allessie, M. A. (2004) · Circulation · doi:10.1161/01.cir.0000143050.22291.2e · Cited by 173
Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent
Antzelevitch, C. N., Belardinelli, L., Wu, L., Fraser, H. I., Zygmunt, A. C., Burashnikov, A., Diego, J. M. D., Fish, J. M., Cordeiro, J. M., Goodrow, R. J., et al. (2004) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840400900106 · Cited by 123
Self-citationFahmi, A. I., Patel, M. K., Stevens, E. B., Fowden, A. L., John, J. E., Lee, K., Pinnock, R., Morgan, K., Jackson, A. P., & Vandenberg, J. I. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00693.x · Cited by 111
Cited by
Atrial Fibrillation Pathophysiology: Implications for Management
Iwasaki, Y.-K., Nishida, K., Kato, T., & Nattel, S. (2011) · Circulation · doi:10.1161/circulationaha.111.019893 · Cited by 852
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Cabrera, J. A., Chen, S. A., Chugh, S. S., Corradi, D., D’Avila, A., Dobrev, D., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2016.05.028 · Cited by 771
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Cabrera, J. A., Chen, S. A., Chugh, S. S., Corradi, D., D'Avila, A., Dobrev, D., et al. (2016) · Europace · doi:10.1093/europace/euw161 · Cited by 762
Heijman, J., Voigt, N., Nattel, S., & Dobrev, D. (2014) · Circulation Research · doi:10.1161/circresaha.114.302226 · Cited by 677
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Zhao, Y., Rafatian, N., Feric, N. T., Cox, B. J., Aschar-Sobbi, R., Wang, E. Y., Aggarwal, P., Zhang, B., Conant, G., Ronaldson-Bouchard, K., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.042 · Cited by 610
Metadata
- Authors
- Burashnikov, A., Di Diego, J. M., Zygmunt, A. C., Belardinelli, L., & Antzelevitch, C.
- Venue
- Circulation
- Published
- 2007-09-25
- Volume
- 116
- Issue
- 13
- Pages
- 1449-1457
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2099007790
- Cited by
- 399
- References
- 18
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine. https://app.cochat.ai/papers/10.1161/circulationaha.107.704890
- The paper
- Burashnikov, A., Di Diego, J. M., Zygmunt, A. C., Belardinelli, L., & Antzelevitch, C. (2007). Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine. Circulation. https://doi.org/10.1161/circulationaha.107.704890
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.